DNAPrint Genomics (DNAG) Stock Price, News & Analysis

Company Overview

DNAPrint Genomics, Inc. was a biotechnology company focused on applying genetic analysis to ancestry and forensic identification. Its technology used genetic markers, including single-nucleotide polymorphisms, to estimate an individual’s biogeographical ancestry and certain externally observable characteristics from a DNA sample.

The company’s historical products included AncestryByDNA, a consumer-oriented genetic ancestry testing service, and DNAWitness, a forensic analysis platform designed to generate investigative predictions about ancestry and selected physical traits when conventional DNA identification methods could not identify a suspect. DNAPrint Genomics also pursued applications for its technology in areas such as personalized medicine and genetic research.

The company was based in Sarasota, Florida, and was historically associated with founder and chief executive Tony Frudakis. Publicly available information about DNAPrint Genomics’ more recent operations, leadership, and active products is limited, and the company does not appear to have a substantial current operating presence.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 5,815 shs
• Market Capitalization: $130 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 10/15/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Biotechnology
• Sub-Industry: Biotechnology
• Current Symbol: OTCMKTS:DNAG
• CIK: N/A
• Web: www.dnaprint.com
• Phone: (941) 366-3400
• Fax: 941-952-9770
• Employees: 24
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 1,294,790,000
• Free Float: N/A
• Market Cap: $130 thousand
• Optionable: Not Optionable
• Beta: N/A